Trials / Sponsors / NImmune Biopharma
NImmune Biopharma
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 1 | 2022-01-30 |
| Withdrawn | Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease Crohn's Disease | Phase 2 | 2021-11-01 |
| Completed | Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers Normal Healthy Volunteers | Phase 1 | 2021-10-28 |
| Terminated | Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease Crohn's Disease | Phase 2 | 2021-05-05 |
| Completed | Efficacy and Safety of Oral BT-11 in Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2019-08-14 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers Normal Healthy Volunteers | Phase 1 | 2018-07-06 |